SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193805-13-001119
Filing Date
2013-06-13
Accepted
2013-06-13 16:38:35
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 e611009_10k-retrophin.htm 10-K 1321926
2 e611009_ex21-1.htm EX-21.1 1663
3 e611009_ex31-1.htm EX-31.1 14785
4 e611009_ex31-2.htm EX-31.2 14912
5 e611009_ex32-1.htm EX-32.1 5636
6 e611009_ex32-2.htm EX-32.2 5929
13 GRAPHIC enzyme.jpg GRAPHIC 14260
14 GRAPHIC compound.jpg GRAPHIC 29205
  Complete submission text file 0001193805-13-001119.txt   3547118

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rtrx-20121231.xml EX-101.INS 305245
8 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20121231.xsd EX-101.SCH 30988
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20121231_cal.xml EX-101.CAL 33886
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20121231_def.xml EX-101.DEF 39142
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20121231_lab.xml EX-101.LAB 180533
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20121231_pre.xml EX-101.PRE 127682
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: 10-K | Act: 34 | File No.: 000-53293 | Film No.: 13911845
SIC: 2834 Pharmaceutical Preparations